Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Journal Article

    Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Teneriello, M. G.; Husain, A.; Sovak, M. A.; Yi, J.; Nycum, L. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Gemcitabine for advanced endometrial cancer: A retrospective study of the Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Grisham, R. N.; Adaniel, C.; Hyman, D. M.; Ma, W.; Iasonos, A.; Aghajanian, C.; Konner, J.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
    Meeting Abstract

    Aghajanian, C.; Blank, S.; Goff, B.; Judson, P.; Nycum, L.; Sovak, M.; Yi, J.; Husain, A.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Intraperitoneal chemotherapy in older women with epithelial ovarian cancer
    Journal Article

    O'cearbhaill, R.; Li, D.; Shi, W.; Thaler, H.; Sabbatini, P. J.; Konner, J.; Hensley, M. L.; Aghajanian, C. A.; Lichtman, S. M.; Tew, W. P.
    Journal of Geriatric Oncology (2012)

    Fulltext@MSK | Save
  • A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers - An analysis of GOG 218
    Meeting Abstract

    Chan, J.; Java, J.; Monk, B.; Alvarez-Secord, A.; Kapp, D.; Birrer, M.; Aghajanian, C.; Bookman, M.; Kattan, M.; Burger, R.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172
    Meeting Abstract

    Barlin, J.; Dao, F.; Zgheib, N. B.; Ferguson, S.; Sabbatini, P.; Hensley, M.; Konner, J.; Tew, W.; Aghajanian, C.; Chi, D.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
    Meeting Abstract

    Álvarez, E.; Brady, W.; Walker, J.; Rotmensch, J.; Zhou, X.; Kendrick, J.; Yamada, S.; Aghajanian, C.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Independent radiologic review of OCEANS, a phase III trial of carboplatin, gemcitabine, and bevacizumab or placebo for the treatment of platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Meeting Abstract

    Aghajanian, C.; Makhija, S.; Rutherford, T.; Sharma, S.; Nycum, L.; Sovak, M.; Nguyen, H.; Yi, J.; Husain, A.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: A 2-cohort, phase 2 study
    Journal Article

    Hensley, M. L.; Kravetz, S.; Jia, X.; Iasonos, A.; Tew, W.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C. A.; Zarwan, C.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
    Journal Article

    Barlin, J. N.; Dao, F.; Zgheib, N. B.; Ferguson, S. E.; Sabbatini, P. J.; Hensley, M. L.; Bell-Mcguinn, K. M.; Konner, J.; Tew, W. P.; Aghajanian, C.; more...
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save